158 related articles for article (PubMed ID: 1909947)
21. Clinical development of Orthoclone OKT3.
Cosimi AB
Transplant Proc; 1987 Apr; 19(2 Suppl 1):7-16. PubMed ID: 3105142
[No Abstract] [Full Text] [Related]
22. Muromonab-CD3 (Orthoclone OKT3): the first monoclonal antibody approved for therapeutic use.
Emmons C; Hunsicker LG
Iowa Med; 1987 Feb; 77(2):78-82. PubMed ID: 3557906
[No Abstract] [Full Text] [Related]
23. Monoclonal antibody OKT3 in cardiac and renal transplantation.
Norman DJ
Bibl Cardiol; 1988; (43):27-32. PubMed ID: 3147656
[No Abstract] [Full Text] [Related]
24. Monoclonal versus polyclonal antibody therapy for prophylaxis against rejection after heart transplantation.
Kormos RL; Herlan DB; Armitage JM; Stein K; Kaufman C; Zeevi A; Duquesnoy R; Hardesty RL; Griffith BP
J Heart Transplant; 1990; 9(1):1-9, discussion 9-10. PubMed ID: 2107288
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic use of the monoclonal antibody Orthoclone OKT3.
Transplant Proc; 1987 Apr; 19(2 Suppl 1):1-58. PubMed ID: 3105133
[No Abstract] [Full Text] [Related]
26. Use of Orthoclone OKT3 as treatment of acute renal allograft rejection and as first-line therapy in kidney transplantation.
Winde G; Dietl KH; Raidt H; Buchholz B; Lison AE; Bünte H
Transplant Proc; 1988 Oct; 20(5 Suppl 6):87-9. PubMed ID: 3140453
[No Abstract] [Full Text] [Related]
27. Use of Orthoclone OKT3 monoclonal antibody to reverse acute renal allograft rejection unresponsive to treatment with conventional immunosuppressive regimens.
Monaco A; Goldstein G; Barnes L
Transplant Proc; 1987 Apr; 19(2 Suppl 1):28-31. PubMed ID: 3105137
[No Abstract] [Full Text] [Related]
28. Therapeutic use of the OKT3 anti-T cell monoclonal antibody: mode of action and side effects.
Chatenoud L
Transplant Proc; 1988 Oct; 20(5 Suppl 6):79-83. PubMed ID: 3140452
[No Abstract] [Full Text] [Related]
29. Orthoclone OKT3 as first-line therapy in acute renal allograft rejection.
Strate M; Jørgensen KA; Rohr N; Elbirk A; Svendsen V; Birkeland SA
Transplant Proc; 1990 Feb; 22(1):219-20. PubMed ID: 2106739
[No Abstract] [Full Text] [Related]
30. Orthoclone OKT3 treatment of acute renal allograft rejection in patients receiving maintenance cyclosporine therapy.
Hirsch RL; Layton PC; Barnes LA; Kremer AB; Goldstein G
Transplant Proc; 1987 Apr; 19(2 Suppl 1):32-6. PubMed ID: 3105138
[No Abstract] [Full Text] [Related]
31. Using OKT3 to reverse cardiac allograft rejection.
Rogers KR; Sinnott JT; Ferguson JE
Heart Lung; 1989 Sep; 18(5):490-6. PubMed ID: 2506149
[TBL] [Abstract][Full Text] [Related]
32. Anaphylaxis and desensitization to the murine monoclonal antibody used for renal graft rejection.
Georgitis JW; Browning MC; Steiner D; Lorentz WB
Ann Allergy; 1991 Apr; 66(4):343-7. PubMed ID: 1901692
[TBL] [Abstract][Full Text] [Related]
33. [Orthoclone OKT3 (Muromonab CD3)--the indications for and manner of its use. Side effects and their prevention].
Filev A; Kumanov Kh; Slavov Ch; Tsvetkov M
Khirurgiia (Sofiia); 1989; 42(6):80-2. PubMed ID: 2517512
[TBL] [Abstract][Full Text] [Related]
34. Experience with Orthoclone OKT3 monoclonal antibody in liver transplantation.
Gordon RD; Tzakis AG; Iwatsuki S; Todo S; Esquivel CO; Marsh JW; Stieber A; Makowka L; Starzl TE
Am J Kidney Dis; 1988 Feb; 11(2):141-4. PubMed ID: 3124609
[TBL] [Abstract][Full Text] [Related]
35. [Treatment of kidney graft rejection with a monoclonal antibody (Orthoclone OKT-3)].
Ladefoged SD; Friedberg M; Glenthøj A
Ugeskr Laeger; 1988 Nov; 150(48):2974-6. PubMed ID: 3144080
[No Abstract] [Full Text] [Related]
36. Prophylactic therapy for rejection after cardiac transplantation. A comparison of rabbit antithymocyte globulin and OKT3.
Kirklin JK; Bourge RC; White-Williams C; Naftel DC; Thomas FT; Thomas JM; Phillips MG
J Thorac Cardiovasc Surg; 1990 Apr; 99(4):716-24. PubMed ID: 2108282
[TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibodies in organ transplantation.
Valdés RH
Transplant Proc; 1996 Dec; 28(6):3293. PubMed ID: 8962277
[No Abstract] [Full Text] [Related]
38. OKT 3: nursing considerations for use in acute renal transplant rejection.
Trusler LA
ANNA J; 1990 Aug; 17(4):299-303. PubMed ID: 2118750
[TBL] [Abstract][Full Text] [Related]
39. OKT3 monoclonal antibody given for ten versus fourteen days as immunosuppressive prophylaxis in heart transplantation.
Hegewald MG; O'Connell JB; Renlund DG; Lee HR; Burton NA; Karwande SV; Jones KW; Lassetter JE; Bristow MR
J Heart Transplant; 1989; 8(4):303-9; discussion 309-10. PubMed ID: 2504897
[TBL] [Abstract][Full Text] [Related]
40. Nashville antithymocyte serum: a safe and efficacious agent for prophylaxis after heart transplantation.
Frist WH; Merrill WH; Eastburn TE; Stewart JR; Hammon JW; Fortune DS; Guy TS; Bender HW
Transplant Proc; 1991 Feb; 23(1 Pt 2):1160-1. PubMed ID: 1846455
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
